News, Events, & Announcements

Golden Helix Featured in Numerous Publications 2020

Jan 12, 2021

Golden Helix continues to innovate and grow, and due to this, we have been garnering attention and praise. We are thrilled to share with you some of the accolades and interest from numerous publications from the last six months. Talking points ranged from diagnosing and tracking Covid-19 infections leveraging NGS…

Read more →

Featured in The Journal of Precision Medicine: Golden Helix’s Recent Release for a New Workflow for Interpretating and Reporting Copy Number Variants in Concordance with the Recently Updated ACMG Guidelines: Introduction

Dec 28, 2020

Have you seen us in The Journal of Precision Medicine? Last week, our team released VarSeq 2.2.2 loaded with a number of updates and VSClinical’s highly-anticipated ACMG-CNV Guideline workflow! We have spent the past several months sharing webcasts and blogs on this new capability. We are honored to also have…

Read more →

Golden Helix’s Virtual 2020 Conference Booth

Oct 27, 2020

In lieu of conferences making the absolutely necessary decision to cancel this year’s conference, we created our Virtual 2020 Conference Booth! Even though it will never compare to the real deal, we hope you enjoy this blog post containing a few events we had planned this year. To start, let…

Read more →

2020 T-Shirt Design Competition Winners

Sep 8, 2020

We would like to thank everyone who participated in our 2020 t-shirt design competition. It was great to see the amount of creativity our community expressed and was certainly a tough decision to make! We are pleased to announce this year’s winners: First Place – Michaela Lucas Michaela Lucas is…

Read more →

Golden Helix Announces New Workflow for the Interpretation and Reporting of Copy Number Variants in Concordance with the Recently Updated ACMG Guidelines

Aug 18, 2020

The detection and interpretation of Copy Number Variants (CNVs) is vital for the clinical evaluation of individuals with a wide range of disorders. Golden Helix has remained at the forefront of CNVs in Next-Gen Sequencing (NGS) data since 2016 with the release of VS-CNV, our solution that allows you to…

Read more →

Golden Helix Named on Inc. 5000 List of Fastest-Growing Private Companies for 2nd Consecutive Year

Aug 12, 2020

Golden Helix has secured its reputation as a global leader in Next-Generation Sequencing (NGS) solutions for over two decades. Today, we are proud to announce that we have been included in the esteemed Inc. 5000 List of rapidly growing American companies. Out of the 6 million businesses in the United…

Read more →

Featured in The European Journal of Clinical and Biomedical Sciences: Investigating COVID-19 Infections Leveraging Next-Gen Sequencing

Jul 8, 2020

It is an honor to be published in the European Journal of Clinical and Biomedical Sciences (Volume 6, Issue 4) in an article co-authored by Dr. Christiane Scherer and myself, “Investigating the Global Spread of SARS-CoV-2 Leveraging Next-Gen Sequencing and Principal Component Analysis.” This study highlights how genomic surveillance of COVID-19…

Read more →

Golden Helix Featured in Various Publications

Jul 8, 2020

Golden Helix has been incredibly fortunate to have been featured in a variety of publications over these last six months. Topics span from the history and future of our company to several new use cases for our solutions that extend into the infectious disease space, recently coming to fruition with…

Read more →

Featured in Clinical OMICs: Enabling Precision Medicine with Cutting-Edge NGS Technologies

Jun 22, 2020

It is an honor to be featured in the Clinical OMICs May/June 2020 issue in a Q&A with the Editor discussing the past, present, and future of Golden Helix. In this article, I detail: Clinical OMICs Article: What has been Golden Helix’s most significant success or contribution to the industry over the…

Read more →

Golden Helix Named as Top 10 Genetic Diagnostics Companies of 2020

May 28, 2020

Today, we’re thrilled to announce that Healthcare Tech Outlook has named Golden Helix among the Top 10 Genetic Diagnostics Companies of 2020. This recognition places us alongside a remarkable group of companies that are leading innovation in genomics, diagnostics, and precision medicine. We are honored to receive this distinction and…

Read more →

Golden Helix Recognized in GHP Magazine’s 2020 Biotechnology Awards

Apr 14, 2020

We are honored to be recognized in this year’s 2020 Biotechnology Awards by GHP Magazine — thank you!Find the full list of winners here. “Covering a variety of verticals, including bio agriculture, bio services, bio industrial and biopharmaceutical, the biotechnology market are under the microscope in Global Health & Pharma’s…

Read more →

Golden Helix Discounted Software for COVID-19 Related Projects

Apr 6, 2020

Supporting the Fight Against COVID-19: Discounted Software Licenses for Clinical Research For more than 20 years, Golden Helix has remained steadfast in our mission to empower precision medicine around the globe. Throughout this time, we’ve had the privilege of supporting clinicians, researchers, and healthcare professionals working at the forefront of…

Read more →

COVID-19 Remote Assistance Program for Golden Helix Users

Mar 13, 2020

At Golden Helix, customer support is our number one priority. This commitment extends beyond technical assistance—it includes the health, safety, and overall well-being of our entire community. During this time of global uncertainty, we want to first acknowledge the incredible dedication of healthcare professionals and frontline workers around the world.…

Read more →

Golden Helix Named as Top 10 World’s Most Trust Worthy Bioanalysis Companies in 2020

Mar 13, 2020

We’re thrilled to share that Golden Helix has been recognized by CIO Look as one of the Top 10 Most Trustworthy Bioanalysis Companies in the World. This recognition highlights our dedication to supporting clinical labs and healthcare organizations with cutting-edge, affordable, and reliable software solutions for genomic data analysis. For…

Read more →

2020 Abstract Competition Winners

Feb 18, 2020

We would like to thank everyone who entered our 2020 Abstract Competition. It is wonderful to read about the different ways Golden Helix software is being applied around the world. It is our pleasure to announce this year’s winners! First Place: Dr. Robert Hamilton and Priyanka Kugamoorthy – SickKids Yearly…

Read more →

Golden Helix Recognized as one of the Top 60 Genetics Blogs on the Web

Feb 11, 2020

We are incredibly grateful to be recognized as one of the Top 60 Genetics Blogs on the Web by Feedspot. Our team is dedicated to educating our readers on how our solutions can help enable precision medicine, and we are so honored to have received this recognition.  On our blog, you will…

Read more →

Introducing Drugs and Trials for Cancer Diagnostics

Jan 23, 2020

When interpreting a variant using the AMP guidelines for somatic variant interpretation, clinicians must determine whether the variant can be considered a biomarker that affects clinical care by predicting sensitivity, resistance, or toxicity to a specific therapy. Such a determination requires the investigation of multiple evidence sources, including clinical trials,…

Read more →

Off to PAG XXVIII!

Jan 7, 2020

We’re packing our bags and getting ready to head out to San Diego, CA for the International Plant & Animal Genome XXVIII meeting (or PAG 2020). This is the largest ag-genomics meeting in the world, bringing together over 3,000 leading genetic scientists and researchers in plant and animal research, and over…

Read more →

Fast Annotations Around the Globe: Our Sydney and Frankfurt Data Mirrors

Dec 3, 2019

If you have watched this blog over time, it would be no surprise that Golden Helix invests a lot in curating genomic annotations for use with our clinical and research analysis products. Often, we spend considerable time on the attention to detail necessary to ensure the best experience for any data source by cleaning, normalizing,…

Read more →

Reflecting on AMP 2019

Nov 14, 2019

Our team has returned from the annual meeting of the Association of Molecular Pathology (AMP 2019), and, as always, I am grateful for all the wonderful experiences we are bringing back with us. The plenary sessions and talks were bountiful, and we were very impressed with the well-organized exhibition. Hats…

Read more →